| Gene symbol | MAGEA4 | Synonyms | CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | MAGE family member A4 | ||||
| Gene symbol | MAGEA8 | Synonyms | CT1.8, MAGE8 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | MAGE family member A8 | ||||
| GTO ID | GTC1766 |
| Trial ID | NCT03247309 |
| Disease | Solid Tumor |
| Altered gene | MAGE-A4|MAGE-A8 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | IMA201 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Phase 1 Study Evaluating Genetically Modified Autologous T Cells Expressing a T-cell Receptor Recognizing a Cancer/Germline Antigen in Patients With Recurrent and/or Refractory Solid Tumors (ACTengine IMA201-101) |
| Year | 2017 |
| Country | United States|Germany |
| Company sponsor | Immatics US, Inc. |
| Other ID(s) | IMA201-101 |
| Cohort 1 | |||||||||
|
|||||||||